1. Home
  2. KWR vs WVE Comparison

KWR vs WVE Comparison

Compare KWR & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KWR
  • WVE
  • Stock Information
  • Founded
  • KWR 1918
  • WVE 2012
  • Country
  • KWR United States
  • WVE Singapore
  • Employees
  • KWR N/A
  • WVE N/A
  • Industry
  • KWR Major Chemicals
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • KWR Industrials
  • WVE Health Care
  • Exchange
  • KWR Nasdaq
  • WVE Nasdaq
  • Market Cap
  • KWR 1.8B
  • WVE 1.7B
  • IPO Year
  • KWR 1985
  • WVE 2015
  • Fundamental
  • Price
  • KWR $104.93
  • WVE $6.56
  • Analyst Decision
  • KWR Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • KWR 4
  • WVE 11
  • Target Price
  • KWR $157.75
  • WVE $22.00
  • AVG Volume (30 Days)
  • KWR 197.2K
  • WVE 1.7M
  • Earning Date
  • KWR 05-01-2025
  • WVE 05-08-2025
  • Dividend Yield
  • KWR 1.88%
  • WVE N/A
  • EPS Growth
  • KWR 3.95
  • WVE N/A
  • EPS
  • KWR 6.51
  • WVE N/A
  • Revenue
  • KWR $1,839,686,000.00
  • WVE $108,302,000.00
  • Revenue This Year
  • KWR $2.57
  • WVE N/A
  • Revenue Next Year
  • KWR $4.77
  • WVE N/A
  • P/E Ratio
  • KWR $15.82
  • WVE N/A
  • Revenue Growth
  • KWR N/A
  • WVE N/A
  • 52 Week Low
  • KWR $95.91
  • WVE $4.25
  • 52 Week High
  • KWR $197.03
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • KWR 37.88
  • WVE 45.49
  • Support Level
  • KWR $98.26
  • WVE $5.72
  • Resistance Level
  • KWR $109.26
  • WVE $7.35
  • Average True Range (ATR)
  • KWR 6.03
  • WVE 0.62
  • MACD
  • KWR 0.50
  • WVE 0.22
  • Stochastic Oscillator
  • KWR 50.03
  • WVE 78.99

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: